FY26 Macrophage Derived Engineered Vesicles to Treat Pediatric Osteosarcoma

Pharmacology, Toxicology and Pharmaceutical Science

1. Osteosarcoma 100%
2. Neoplasm 70%
3. Lung Metastasis 40%
4. Guanosine Phosphate 40%
5. Cisplatin 30%
6. Normal Human 20%
7. Clinical Trial 20%
8. Ovary Cancer 20%
9. Chemotherapy Regimens 20%
10. Adverse Event 20%
11. Diseases 10%
12. Malignant Neoplasm 10%
13. Anti-Inflammatory Drug 10%
14. Dose-Response Study 10%
15. Tumor Microenvironment 10%
16. Murine 10%
17. Table Salt 10%
18. Micrometastasis 10%
19. Nanoparticle Drug Delivery 10%